These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 17219009)
21. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348 [TBL] [Abstract][Full Text] [Related]
22. Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Pfister M; Zalaman IM; Blumenstock G; Mauz PS; Baumann I Acta Otolaryngol; 2009 Aug; 129(8):862-6. PubMed ID: 18855162 [TBL] [Abstract][Full Text] [Related]
23. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. Abdalla SA; Letarte M J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500 [TBL] [Abstract][Full Text] [Related]
24. Disease-associated mutations in conserved residues of ALK-1 kinase domain. Abdalla SA; Cymerman U; Johnson RM; Deber CM; Letarte M Eur J Hum Genet; 2003 Apr; 11(4):279-87. PubMed ID: 12700602 [TBL] [Abstract][Full Text] [Related]
25. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis. Lenato GM; Suppressa P; Giordano P; Guanti G; Guastamacchia E; Triggiani V; Amati L; Resta F; Covelli V; Jirillo E; Sabbà C Curr Pharm Des; 2007; 13(36):3656-64. PubMed ID: 18220803 [TBL] [Abstract][Full Text] [Related]
26. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067 [TBL] [Abstract][Full Text] [Related]
27. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Berg JN; Gallione CJ; Stenzel TT; Johnson DW; Allen WP; Schwartz CE; Jackson CE; Porteous ME; Marchuk DA Am J Hum Genet; 1997 Jul; 61(1):60-7. PubMed ID: 9245985 [TBL] [Abstract][Full Text] [Related]
28. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Wallace GM; Shovlin CL Thorax; 2000 Aug; 55(8):685-90. PubMed ID: 10899246 [TBL] [Abstract][Full Text] [Related]
29. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management. Stuhrmann M; El-Harith el-HA Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283 [TBL] [Abstract][Full Text] [Related]
30. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Dakeishi M; Shioya T; Wada Y; Shindo T; Otaka K; Manabe M; Nozaki J; Inoue S; Koizumi A Hum Mutat; 2002 Feb; 19(2):140-8. PubMed ID: 11793473 [TBL] [Abstract][Full Text] [Related]
31. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Abdalla SA; Gallione CJ; Barst RJ; Horn EM; Knowles JA; Marchuk DA; Letarte M; Morse JH Eur Respir J; 2004 Mar; 23(3):373-7. PubMed ID: 15065824 [TBL] [Abstract][Full Text] [Related]
32. Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures. Sadick H; Sadick M; Götte K; Naim R; Riedel F; Bran G; Hörmann K Wien Klin Wochenschr; 2006 Mar; 118(3-4):72-80. PubMed ID: 16703249 [TBL] [Abstract][Full Text] [Related]
33. [Analysis of molecular background of hereditary haemorrhagic telangiectasia--Rendu-Osler-Weber disease--preliminary results]. Kostrzewska-Poczekaj M; Wróbel M; Rydzanicz M; Szyfter W; Szyfter K Otolaryngol Pol; 2008; 62(6):700-4. PubMed ID: 19205515 [TBL] [Abstract][Full Text] [Related]
36. ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia. Argyriou L; Pfitzmann R; Wehner LE; Twelkemeyer S; Neuhaus P; Nayernia K; Engel W Liver Transpl; 2005 Sep; 11(9):1132-5. PubMed ID: 16123970 [TBL] [Abstract][Full Text] [Related]
37. Retention in the endoplasmic reticulum is the underlying mechanism of some hereditary haemorrhagic telangiectasia type 2 ALK1 missense mutations. Hume AN; John A; Akawi NA; Al-Awadhi AM; Al-Suwaidi SS; Al-Gazali L; Ali BR Mol Cell Biochem; 2013 Jan; 373(1-2):247-57. PubMed ID: 23124896 [TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of a family with hereditary hemorrhagic telangiectasia associated with hepatic arteriovenous malformation. Lin WD; Wu JY; Hsu HB; Tsai FJ; Lee CC; Tsai CH J Formos Med Assoc; 2001 Dec; 100(12):817-9. PubMed ID: 11802521 [TBL] [Abstract][Full Text] [Related]
39. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia. Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701 [TBL] [Abstract][Full Text] [Related]
40. ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation. Alsina-Sanchís E; García-Ibáñez Y; Figueiredo AM; Riera-Domingo C; Figueras A; Matias-Guiu X; Casanovas O; Botella LM; Pujana MA; Riera-Mestre A; Graupera M; Viñals F Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1216-1229. PubMed ID: 29449337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]